Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Genotyping Kit for Target Alleles: From Sample to Signal
2026-08-24
The Genotyping Kit for target alleles enables rapid PCR-ready DNA preparation across insects, tissues, fishes, and cells. This article presents a genotype-to-phenotype workflow inspired by mechanistic colitis research, emphasizing assay decisions, controls, and the limits of direct PCR.
-
Anagliptin (SK-0403): From DPP-4 to Vascular Biology
2026-08-24
Anagliptin (SK-0403) is more than a tool for studying incretin biology. Evidence from rabbit aortic rings connects its established DPP-4 inhibition mechanism with endothelium-independent vasorelaxation involving Kv channels and SERCA-dependent calcium handling, creating a practical framework for translational diabetes and vascular research.
-
Bradykinin Workflows for Vascular Research
2026-08-23
Build reproducible vascular assays around Bradykinin, from endothelial permeability screens to smooth muscle contraction research. This guide pairs practical pilot parameters with troubleshooting and a cautious extension of findings from a diabetic cognitive dysfunction study.
-
Nonselective β-Blockers Delay HCT Regeneration
2026-08-22
The reference study shows that nonselective β-adrenergic receptor inhibitors impair hematopoietic regeneration after transplantation, whereas β1-selective inhibition largely preserves engraftment. By combining mouse transplantation models with human clinical data, the work identifies receptor selectivity and transplant context as important variables for post-HCT biology and experimental design.
-
Polymyxin B: From Membrane Damage to Translation
2026-08-22
A translational framework for using Polymyxin B sulfate in Gram-negative infection research, dendritic cell assays, and sepsis models while connecting antimicrobial mechanism to immune-context design and experimental risk management.
-
Vacuolin-1 for Lysosomal Exocytosis Research
2026-08-21
Vacuolin-1 enables a targeted test of lysosome–plasma membrane fusion in secretion, membrane repair, and disease-model assays. This workflow combines β-hexosaminidase release, surface LAMP-1, viability controls, and growth-factor readouts to distinguish altered lysosomal exocytosis from nonspecific cell damage.
-
Brain-to-Spinal Circuits Control Mechanical Allodynia
2026-08-20
The reference study identifies a contralateral lPBNOprm1–dmHPdyn–spinal dorsal horn pathway that limits the spread and persistence of mechanical allodynia in mice. By combining circuit mapping with projection-specific inhibition, peptide deletion, receptor blockade, and pathway activation, the authors show how hypothalamic dynorphin and spinal κ-opioid signaling regulate bilateral pain hypersensitivity.
-
RNASEH1-AS1 in Hepatocellular Carcinoma
2026-08-20
A 2024 study integrates TCGA analysis, network biology, prognostic modeling, and laboratory validation to identify RNASEH1-AS1 as a candidate oncogenic lncRNA in hepatocellular carcinoma. Its findings connect RNASEH1-AS1 expression with tumor grade, AFP status, survival, immune-cell infiltration, and DKC1-dependent RNA stability, while also highlighting the need for independent clinical validation.
-
Molecular Basis of TRPM3 Regulation
2026-08-19
Yin and colleagues define how neurosteroids, synthetic agonists, and primidone regulate the Ca2+-permeable TRPM3 channel using cryo-EM, electrophysiology, molecular dynamics, and mass spectrometry. The structures connect ligand-binding sites with channel gating and disease-relevant gain-of-function mechanisms, providing a framework for interpreting TRPM3 pharmacology in pain and neurodevelopmental disorders.
-
Ibotenic Acid: NMDA Receptor Agonist Guide
2026-08-19
Ibotenic acid is an NMDA receptor agonist and metabotropic glutamate receptor agonist used to perturb excitatory neurotransmission in preclinical neuroscience. Its defined composition, documented solubility, and controlled storage requirements support use as a neuroscience research tool, but pain-circuit findings should not be treated as direct validation of an ibotenic acid neurodegenerative disease model.
-
AMPK, ULK1, and the Energy Stress Response
2026-08-18
The reference study challenges the prevailing view that AMPK universally promotes autophagy during glucose deprivation. Its experiments show that AMPK suppresses ULK1 signaling during severe energy stress while preserving the autophagy machinery for later recovery, establishing a context-dependent model of energy-stress adaptation.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-08-18
The reference study challenges the prevailing view that AMPK uniformly stimulates autophagy during glucose deprivation. Using pathway-specific signaling and autophagy readouts, it shows that AMPK suppresses ULK1-driven autophagy during acute energy stress while preserving the autophagy machinery for recovery after stress is relieved.
-
Isoproterenol Sulfate Dihydrate: Assay Guide
2026-08-17
A scenario-based guide to using Isoproterenol sulfate dihydrate in viability, proliferation, cytotoxicity, and human pacemaker models. It explains how SKU C6402 can improve interpretation through controlled dosing, compatible formulation, and documented quality attributes.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-08-17
This study shows that intestinal epithelial TM6SF2 protects against MASH by preserving barrier function and controlling host–microbiota interactions, rather than acting only through hepatic lipid metabolism. Its genetic, microbiome-transfer and pharmacological experiments identify gut-derived lysophosphatidic acid as a mechanistic link between intestinal TM6SF2 deficiency and liver steatohepatitis.
-
A-769662: Interpreting AMPK Signals in Cell Stress
2026-08-16
A-769662 is a reversible AMPK activator that can separate energy-sensing kinase activity from nutrient-starvation effects. This guide connects its metabolic and proteasome-related pharmacology with revised autophagy biology to improve assay design and interpretation.